None listed
Conditions
Interventions
None listed
Sponsors
Namaskar Ayurved Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Healthy Male and female subjects 2. Willing to comply with all requirements of the study.
Exclusion criteria
Exclusion criteria: 1. Subjects with a known current history of chronic skin diseases or autoimmune diseases, such as atopic dermatitis, psoriasis, chronic urticaria, vitiligo and rosacea 2. Subjects with a tattoo, a scar, moles, too many hairs or anything on the Right leg which might interfere with the evaluation. 3. Subjects with intensive exposure to sunlight or UV-rays within the previous month and foreseen during the study. 4. Subjects who have used facial skin hydrating and soothing products (topicals), moisturizing cream, lotion or oil within 21 days before entering the trial 5. Subjects on any other investigational products within 1 month prior to randomization 6. Subjects with known current tuberculosis, HIV, ischemic heart disease, cancer, kidney failure, liver failure 7. Pregnant and lactating women 8. Known hypersensitivity to any of the ingredients of Namaskar Ayurved Restore and Refresh Vetiver Concentrate 9. Other conditions, which in the opinion of the investigators, make patient unsuitable for enrolment or could interfere with his/her participation in, and completion of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in facial cutaneous moisturizationTimepoint: Day 0, 24 hrs. post skin patch test application, 48 hrs. post skin patch test application, Day 3, Day 7 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Changes in overall skin (facial) texture/roughness (Tactile) 2. Changes in overall skin (facial) texture/roughness (Visual) 3. Changes in overall facial skin luminosity/radiance 4. Assessment of 24 hr skin patch test 5. Changes in freshness of the facial skin 6. Changes in facial hyperpigmentation/ dark spot 7. Changes in facial scar 8. Changes in blemishes on facial skin 9. Assessment of mood 10. Global assessment for overall change 11. Assessment of post treatment tolerability of study drug 12. Assessment of adverse events Timepoint: Screening / Baseline visit, visit 1 (24 hrs. post skin patch test application), visit 2 (48 hrs. post skin patch test application, visit 3 (Day 3), visit 4 (Day 7) | — |
Countries
India
Contacts
Public ContactDr Sanjay Tamoli
Target Institute of Medical Education and Research Pvt. Ltd.
Outcome results
None listed